CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity

• Authors: OBERMANNOVA R.; DEMLOVÁ Regina; SELINGEROVA I.; DOUBEK M.; OKROUHLICOVA D.; MLNAŘÍKOVÁ Marie; PILÁTOVÁ Kateřina; NEVRLKA Jiří; LEJDAROVÁ Hana; WEINBERGEROVA B.; CERMAKOVA Z.; VALÍK Dalibor; MAYER Jiří; KISS Igor; ZDRAŽILOVÁ DUBSKÁ Lenka
• Year of publication: 2021
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: SARS-CoV-2 infection may be a threat for those undergoing active anti-cancer therapy. We aim to study adverse events, efficacy, and immune response in Covid-19 vaccinated patients focusing on possibly interfering therapy.